Novacyt【ALNOV】銘柄情報

Novacyt (ALNOV) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

0.41

( 1.99% )

買値

0.41

売値

0.4145

出来高

64,365

0.405 日の範囲 0.415

0.29 52 週間の範囲 1.04

時価総額

29.709M

前日終値

0.402

始値

0.41

時刻

300

0.41

最終取引時間

17:41:03

財務取引量

VWAP

平均取引量 (3 か月)

1,215,698 €

発行済株式数

72,461,162

配当利回り

PER

-1.07

1 株当たり利益 (EPS)

-0.32

歳入

20.03M

純利益

-22.88M

Novacyt S.A., together with its subsidiaries, develops, manufactures, and commercializes a range of molecular assays and instrumentation to deliver workflows and services for human health, animal health, and environmental sectors. It operates through Yourgene Health and Primer Design segments. The Y... Novacyt S.A., together with its subsidiaries, develops, manufactures, and commercializes a range of molecular assays and instrumentation to deliver workflows and services for human health, animal health, and environmental sectors. It operates through Yourgene Health and Primer Design segments. The Yourgene Health segment delivers molecular diagnostic and screening solutions, across reproductive health and precision medicine. The Primer Design segment designs, manufactures, and markets molecular real-time qPCR testing devices and reagents in the areas of infectious diseases. It operates in the United Kingdom, France, Europe, the United States, the Asia Pacific, the Middle East, and Africa. The company was incorporated in 2006 and is based in Le Vésinet, France. 詳細を表示

セクター

Healthcare

業界

Medical Equipment & Supplies

ウェブサイト

www.novacyt.com

本社

Le Vésinet, France

設立

2026

Novacyt is listed in the Healthcare sector of the ユーロネクスト with ticker ALNOV. The last closing price for Novacyt was 0.40 €. Over the last year, Novacyt shares have traded in a share price range of 0.29 € to 1.04 €.

Novacyt currently has 72,461,162 shares in issue. The market capitalisation of Novacyt is 29.71 € million. Novacyt has a price to earnings ratio (PE ratio) of -1.07.

Novacyt S.A. ("Novacyt", the "Company" or the "Group"): DHSC Claim Update – Trial Date Listed

Regulatory News: Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that the High Court...

Novacyt S.A. ("Novacyt", the "Company" or the "Group") Rapport d’activité pour l'année 2022

Le chiffre d'affaires et l'EBITDA sont conformes aux prévisions. Concentration sur la stratégie de croissance post-COVID-19 pour devenir un...

Novacyt S.A. ("Novacyt", la "Société" ou le "Groupe"): Départ à la retraite d’un Administrateur non-exécutif

Regulatory News: Novacyt (EURONEXT GROWTH : ALNOV ; AIM : NCYT), spécialiste international du diagnostic clinique, annonce qu'Edwin Snape a...

Novacyt S.A. ("Novacyt", the "Company" or the "Group"): Approval of genesig® COVID-19 3G PCR Test in the UK Under CTDA Legislation

Regulatory News: Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that the Company’s...

Novacyt S.A. (« Novacyt », la « Société » ou le « Groupe »): Changement au niveau de la direction

Regulatory News: Novacyt (EURONEXT GROWTH : ALNOV ; AIM : NCYT), spécialiste international du diagnostic clinique, annonce que David Allmond...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.0225	-5.20231213873	0.4325	0.46	0.39	293084	0.41524053	DE
4	-0.242	-37.1165644172	0.652	0.695	0.39	919427	0.56511043	DE
12	0.035	9.33333333333	0.375	1.04	0.29	1438761	0.64198287	DE
26	-0.038	-8.48214285714	0.448	1.04	0.29	790653	0.61674991	DE
52	-0.085	-17.1717171717	0.495	1.04	0.29	465818	0.59312433	DE
156	-0.053	-11.4470842333	0.463	1.59	0.29	458440	0.74157701	DE
260	-3.422	-89.3006263048	3.832	5.89	0.29	545053	1.74344622	DE